S2-E8.2 – Previewing NASH-TAG 2021: Day Two
Stephen Harrison previews Day Two of NASH-TAG while Ian Rowe, Louise Campbell and Roger Green the issues that each of them anticipate most eagerly
February 27, 2021
Stephen Harrison previews Day Two of NASH-TAG while Ian Rowe, Louise Campbell and Roger Green the issues that each of them anticipate most eagerly
Stephen Harrison previews NASH-TAG 2021, the pre-eminent NASH drug development meeting, which will take place from March 10-12
The Surfers and guests Vlad Ratziu and Mazen Noureddin discuss key lessons learned in 2020 about Drugs and Diagnostics
Guest Surfer and regular listener Dr. Ian Rowe joins the Surfers to discuss how everyday patient treatment in the clinic once was and how COVID-19 and the news we discuss weekly on SurfingNASH have changed practice.
The Surfers discuss the Global Liver Institute’s campaign to educate and motivate key stakeholder groups on the value of non-invasive liver testing.
The Surfers and guest Joern Schattenberg consider the implications of a Digital ILC presentation stating that the liver, not cardiovascular disease, is the leading cause of death for NAFLD patients.
